Market Overview
The blood preparation market encompasses the collection, processing, fractionation, and distribution of blood components and their derived therapeutic products. Whole blood is typically separated into red blood cells, platelets, plasma, and cryoprecipitate, which are then used in transfusion medicine, hematology, oncology, trauma care, and the production of plasma-derived drugs such as immunoglobulins, clotting factors, and albumin. Growing healthcare access in emerging economies, alongside continued investment in advanced blood bank technologies, underpins the sector's strong upward trajectory.
- •Global market valued at approximately $51.74 billion in 2025 with a 5.81% CAGR.
- •Whole blood and its components are the foundational product category of the industry.
- •Demand is closely tied to surgical procedures, trauma care, and chronic disease treatment.
Growth Drivers
An aging global population is increasing the prevalence of conditions that require blood-derived therapies, including cancer, hemophilia, and immune deficiencies. Rising rates of road accidents and complex surgical procedures are also lifting demand for transfusable components, while expanding access to healthcare in developing regions is broadening the patient pool. At the same time, the growing use of immunoglobulins and recombinant clotting factors is strengthening the case for expanded plasma collection and fractionation capacity.
- •Rising prevalence of chronic and hematological disorders increases component demand.
- •Greater surgical volumes and trauma cases drive need for transfusable products.
- •Plasma-derived therapeutics continue to be a high-value growth segment.
Segmentation and Regional Analysis
The market is commonly segmented by product type into whole blood and blood components, with further splits across red blood cells, platelets, plasma, and white blood cells, as well as by application such as transfusion medicine, diagnostics, and research. North America currently leads the global market, supported by mature blood banking networks, high plasma collection volumes, and strong reimbursement frameworks. Asia-Pacific is forecast to be the fastest-growing region, propelled by healthcare investment in China and India, expanding donor bases, and rising demand for advanced therapies.
- •Product segmentation centers on whole blood and its individual components.
- •North America holds the leading share due to established infrastructure.
- •Asia-Pacific is projected to record the strongest growth through the forecast period.
Trends and Outlook
What are the recent trends and outlook?
Technological innovation in pathogen reduction, automated blood processing, and component separation is improving product safety, yield, and supply chain efficiency. Concurrently, the shift toward personalized medicine is driving interest in more targeted blood-derived therapies and recombinant alternatives that complement traditional products. With strong underlying demand and ongoing capacity expansion, the blood preparation market is expected to maintain steady growth through the next decade.
- •Pathogen reduction and automation are reshaping blood component processing.
- •Personalized and recombinant therapies are emerging alongside traditional products.
- •Capacity expansion and improved donor networks remain central to long-term growth.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.